This ‘longevity drug’ may weaken gains from exercise

A drug taken by thousands of Americans to improve longevity might have an unexpected side effect, a study has found. It may blunt some of the health benefits of exercise. The drug, rapamycin, is approved by the Food and Drug Administration to prevent organ-transplant rejection in people. But recent...

Redirecting to full article...